Novartis’ chronic myeloid leukemia drug Scemblix will now be available to newly diagnosed patients, the FDA announced on Tuesday.
Scemblix was first approved in 2021 …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
What You Should Know: TapestryHealth, a multi-specialty healthcare company, announced a $25M credit investment from Catalio Capital Management, a leading multi-strategy investment firm focused on
The intravenous antibiotic has shown activity against multi-drug resistant strains causing complicated urinary tract infections. Credit: plo / Shutterstock. Meitheal Pharmaceuticals has expanded its biopharmaceutical
From discovering new genetic code connections to advancing surgery, companies around the world are introducing artificial intelligence (AI), machine learning (ML) and robotics into their